Analyst Price Targets — NERV
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| August 14, 2026 8:04 am | Andrew Tsai | Jefferies | $10.00 | $3.92 | StreetInsider | Jefferies Upgrades Minerva Neurosciences (NERV) to Buy |
| December 1, 2025 8:10 pm | — | Jefferies | $5.00 | $3.80 | TheFly | Minerva price target raised to $5 from $3 at Jefferies |
| August 7, 2024 6:09 am | Douglas Tsao | H.C. Wainwright | $5.00 | $2.94 | TheFly | Minerva price target lowered to $5 from $7 at H.C. Wainwright |
| May 2, 2024 6:49 am | Douglas Tsao | H.C. Wainwright | $7.00 | $2.40 | StreetInsider | Minerva Neurosciences (NERV) PT Lowered to $7 at H.C. Wainwright |
Latest News for NERV
BURLINGTON, Mass., Aug. 28, 2026 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system disorders, today announced that management will participate in two upcoming investor conferences.
Minerva Neurosciences, Inc (NASDAQ: NERV - Get Free Report) has been assigned an average rating of "Reduce" from the four brokerages that are covering the stock, MarketBeat.com reports. Two equities research analysts have rated the stock with a sell recommendation, one has assigned a hold recommendation and one has given a buy recommendation to the company.
Confirmatory Phase 3 trial of roluperidone (MIN-101C19) ongoing with topline efficacy data expected 2H 2027 Scientific Advisory Board of leading experts in psychiatry and neuroscience established to guide the confirmatory Phase 3 trial of roluperidone Roluperidone remains the only late-stage drug candidate for this high-need population BURLINGTON, Mass., Aug. 07, 2026 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc.…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for NERV.
U.S. House Trading
No House trades found for NERV.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.